Medical Oncologist
CION Cancer Clinics
Cholangiocarcinoma in India: what is different here | CION Cancer Clinics
The cancer itself behaves the same in India as anywhere else. What differs is the path to it: the causes doctors look for, how late it is often found, how often it is mistaken for secondary cancer, and whether the gene tests that open up newer treatment are done. This page explains each of these for intrahepatic cholangiocarcinoma, and what to ask for. At CION Cancer Clinics in Hyderabad, our oncologists explain liver cancer in plain words and plan care around you and your family.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Is cholangiocarcinoma different in India?
- What is actually different for a patient in India?
- What should happen after a scan shows a mass in the liver?
- Which words will you see, and what do they mean?
- What do families in India often believe about this cancer?
- What can this page not tell you?
- Common questions about cholangiocarcinoma in India
The short answer
Is cholangiocarcinoma different in India?
The disease itself behaves the same way in India as anywhere else. What differs is the journey: the causes behind it, how late it is found, how often it is mistaken for another cancer, and whether the tests that open up newer treatment are actually done. This page is about intrahepatic cholangiocarcinoma, a cancer that starts in the small bile ducts inside the liver.
Primary, not secondary
Most people told there is "cancer in the liver" have cancer that spread there from the bowel, pancreas, breast or elsewhere. Cholangiocarcinoma is different. It starts in the liver's own bile ducts, so it is a primary liver cancer. If your doctors suspect spread from another organ, the page on why cholangiocarcinoma is often mistaken for secondary cancer explains how the two are told apart.
Why the Indian picture is hard to see
Indian cancer registries usually count liver cancer and intrahepatic bile duct cancer together, in one line. That makes it hard to say how common cholangiocarcinoma is here, or whether it is rising in a particular state. Doctors in Hyderabad see it regularly, but the national numbers are thin. Treat any confident figure you read online with caution.
Where the evidence is thin, this page says so rather than guessing.Four real differences
What is actually different for a patient in India?
None of these change the biology of the tumour. They change how quickly it is found and how fully it is tested.
The causes behind it
In parts of East Asia, liver fluke infection drives many cases. That is not the main story in India. Here, long-standing hepatitis B or C, cirrhosis, fatty liver with diabetes, and stones inside the bile ducts are the risks doctors look for. Many patients have none of these.
A risk factor is not a fault. Most people with these conditions never develop this cancer.It is often found late
Inside the liver, this cancer can grow quietly. Vague tiredness, weight loss or a dull ache are easy to put down to gas or acidity. Many people first come with a large tumour seen on an ultrasound done for something else.
It is often labelled the wrong cancer
Under the microscope it looks like an adenocarcinoma, the same family as bowel, stomach and pancreatic cancer. Without careful pathology, a report may say "metastatic adenocarcinoma, primary unknown". Families then spend weeks searching for a cancer that is not there.
Molecular testing is often skipped
A good share of these tumours carry a gene change that a targeted medicine can act on. Testing for them costs money and needs enough tissue, so it is often left out. That can close doors before anyone knew they were there.
Not sure whether this applies to you?
Ask an oncologistGetting the diagnosis right
What should happen after a scan shows a mass in the liver?
A proper liver scan
A triple-phase CT or an MRI shows how the mass takes up contrast. This helps tell cholangiocarcinoma from HCC and from secondary cancer. CION arranges these scans through accredited diagnostic partners.
A biopsy with enough tissue
Unlike some HCC, this cancer almost always needs a biopsy. Ask that enough tissue is taken for special stains and for gene testing later. The page on why a biopsy is needed here explains why.
A search for any other primary
Before the label is settled, doctors usually check the bowel, stomach and pancreas with scans or an endoscopy. This step stops the wrong treatment being given.
A tumour board review
At CION, medical, surgical and radiation oncologists look at the scans and the pathology together. They decide whether surgery is possible before anything else begins.
Molecular profiling
Every biliary cancer should have its DNA tested. The results may point to a targeted medicine or immunotherapy, though not every test finds one.
On your report
Which words will you see, and what do they mean?
- Intrahepatic cholangiocarcinoma
- Cancer of the small bile ducts inside the liver. Often shortened to iCCA.
- Adenocarcinoma
- A cancer of gland-like cells. It is a description of the cells, not a statement of where the cancer began.
- Immunohistochemistry (IHC)
- Special stains on the biopsy that help the pathologist work out which organ the cancer came from.
- CA 19-9
- A blood marker that can be raised in this cancer, but also with blocked bile or infection. It cannot diagnose on its own.
- FGFR2 fusion, IDH1 mutation
- Two of the gene changes doctors look for. Each has a medicine designed to act on it.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families in India often believe about this cancer?
"He never drank, so it cannot be a liver cancer."
Many people with cholangiocarcinoma have never touched alcohol and have a normal liver otherwise. It is not a disease of drinking, and nobody should be blamed for it.
"The report says the primary is unknown, so treatment must wait."
A second look at the biopsy, with the right stains, often settles the answer. Ask whether cholangiocarcinoma has been considered before accepting "unknown" as final.
"Gene testing is only for rich people abroad."
Molecular profiling is done in India, through accredited laboratories. Cost varies by test and by lab, so ask for a written estimate. It is worth asking about, not assuming it is out of reach.
"A liver tonic will shrink the lump."
No herbal tonic treats this cancer, and some can injure a liver already under strain. Tell your oncologist what you are taking, so it can be checked without anyone judging you.
Did you know
Some medicines that target FGFR2 and IDH1 changes are not routinely available in India, or reach patients only through import or a trial. Your oncologist can tell you what is available now, because this changes. Read more on why every biliary cancer should be molecularly tested.
Being straight with you
What can this page not tell you?
It cannot tell you whether the mass on your scan is cholangiocarcinoma. Only a biopsy, read by a pathologist and reviewed alongside your scans, can answer that. It also cannot tell you how your cancer will behave, or how long anyone will live with it. Nobody can read that from a web page.
It cannot interpret your reports
The same words on two reports can mean different things. If you are holding a biopsy or scan report, bring it to an oncologist who can see the images and the slides, not just the text.
Who this does not apply to
This page is not about cancer that spread to the liver from the bowel or elsewhere, or about HCC, the more common primary liver cancer. It is not about gallbladder cancer either, which has its own section on gallbladder cancer. Bile duct cancer just outside the liver, where the main ducts join, is covered on the page on perihilar cholangiocarcinoma.
If you are unsure what your report means, call the helpline and someone will help you find the right specialist.Questions we are asked
Common questions about cholangiocarcinoma in India
Is cholangiocarcinoma becoming more common in India?
Doctors around the world report seeing more intrahepatic cholangiocarcinoma, partly because scans and pathology have improved. In India, registries usually count it together with other liver cancers, so the trend here is genuinely unclear. Be cautious of any exact figure quoted for India.
Is liver fluke a cause in India?
Liver fluke infection is a major cause in parts of East Asia, where certain raw freshwater fish are eaten. It is not thought to be a main driver in India. Here, doctors look more at long-standing hepatitis, cirrhosis, fatty liver and stones in the bile ducts, though many patients have no clear cause.
Why was my father first told he had secondary cancer?
This cancer looks like adenocarcinoma under the microscope, the same as bowel or pancreatic cancer. Without special stains and a search for another primary, it can be labelled secondary. A review of the biopsy and scans by a tumour board often clarifies it.
Is cholangiocarcinoma curable?
It can be curable when it is found early enough to be removed completely with surgery. Many people are diagnosed later, when treatment aims to control the cancer and keep life comfortable. Your team will explain which situation applies to you, after staging and a tumour board review.
Should every patient have molecular testing?
Yes, guidelines recommend testing the tumour's DNA for biliary cancers, because some have changes a targeted medicine can act on. Not every test finds one. Ask early, so the biopsy keeps enough tissue and the results are ready when decisions are made.
Are targeted medicines for this cancer available in India?
Some are, some are not, and some reach patients only through import or a clinical trial. Approval and supply change, so ask your oncologist what is available at the time. Immunotherapy and chemotherapy are given at CION centres.
Do we need to travel to Hyderabad for treatment?
Not always. Scans, biopsy slides and reports can often be reviewed first, so you know whether the trip is needed. Many families from Telangana and Andhra districts come once for the plan, then continue parts of treatment closer to home.
Can Aarogyasri or Ayushman Bharat help with costs?
These schemes can cover parts of cancer treatment for eligible families, depending on what is listed and where it is done. The rules and covered items change, so check at the time. CION's team helps with the scheme paperwork and can tell you what applies.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Bile Duct Cancer Risk Factors
- American Cancer Society — Bile Duct Cancer Targeted Therapy
- ICMR-NCDIR — National Centre for Disease Informatics and Research
- Cancer Research UK — Bile duct cancer (Cholangiocarcinoma)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Intrahepatic cholangiocarcinoma: what it isThe basics, before the Indian pictureWhy cholangiocarcinoma is often mistaken for secondary cancerIf your report says the primary is unknownWhy every biliary cancer should be molecularly testedThe test that can open up targeted optionsWhat causes intrahepatic cholangiocarcinomaThe risk factors, without blame
Talk to us
Was your biopsy report unclear about where the cancer began?
Send us the scans and the biopsy report and our tumour board can review them with you. We will tell you plainly what else is needed before treatment is decided. One helpline serves every CION centre.